MedPath

Effects of Memantine on the incidence of Delirium

Phase 3
Conditions
Delirium.
Postoperative Delirium
Registration Number
IRCT2016061324236N2
Lead Sponsor
Vice chancellor for research Yazd Shahid Sadoughi University of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

patients aged 50 to 70 years, Signing the informed consent form. Exclusion criteria: EF (ejection fraction) of less than 35%, alcohol and drug abuse, pregnancy and lactation, brain damage, kidney failure (creatinine greater than 1.4), liver failure, scores of MMSE (Mini-Mental State Examination) less than 22? concurrent use of Cholinesterase inhibitors.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delirium. Timepoint: 3 days after operation. Method of measurement: Questionnaire of CAM-ICU.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: 3 days after operation. Method of measurement: Examination and test results.
© Copyright 2025. All Rights Reserved by MedPath